recent articles
Proscia: The diagnostic services provider projects DermAI may decrease turnaround time for melanoma cases by 30-40%. GENEVA and PHILADELPHIA – September 14, 2022 – Unilabs, a leading diagnostic services provider, and Proscia®, a leading...
Proscia Application paves the way for digital pathology’s first suite of process automation solutions and launches alongside new version of the Concentriq for Research platform PHILADELPHIA - MAY 17, 2022 - Proscia®, a leader in digital and...
Findings of multi-site study highlight potential of technology in real-world practice PHILADELPHIA – October 5, 2021 – Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new...
Collaboration brings computational pathology to one of Europe’s largest laboratory networks PHILADELPHIA & STOCKHOLM--(BUSINESS WIRE)--Proscia®, a leading provider of digital and computational pathology solutions, and Unilabs, a...
Proscia® Named to 2019 CNBC Upstart 100 List of Most Promising Star...
- Artificial Intelligence
- Business
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- General Healthcare News
- Image Analysis
- Informatics
- Laboratory Management & Operations
- New Digital Imaging Technologies
- Pathology News
- Vendor products
Recognized for disrupting 150-year-old practice of pathology with artificial intelligence to improve cancer patient outcomes Proscia, a leading provider of digital pathology software, has been named to the CNBC Upstart 100, an exclusive...
U.S. Patent No. 10,460,150 centers around the use of machine learning to classify skin biopsies PHILADELPHIA, October 30, 2019 – Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,460,150 by...